Literature DB >> 19644135

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

Mario Cazzola.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19644135      PMCID： PMC2719025          DOI： 10.3324/haematol.2009.007682

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  23 in total

1.  Myelodysplastic syndromes--coping with ineffective hematopoiesis.

Authors:  Mario Cazzola; Luca Malcovati
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

2.  Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.

Authors:  M Stetler-Stevenson; D C Arthur; N Jabbour; X Y Xie; J Molldrem; A J Barrett; D Venzon; M E Rick
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

Review 3.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

4.  Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach.

Authors:  John M Bennett; Attilio Orazi
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

Review 5.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

6.  Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.

Authors:  Matteo Giovanni Della Porta; Luca Malcovati; Emanuela Boveri; Erica Travaglino; Daniela Pietra; Cristiana Pascutto; Francesco Passamonti; Rosangela Invernizzi; Alessandro Castello; Umberto Magrini; Mario Lazzarino; Mario Cazzola
Journal:  J Clin Oncol       Date:  2008-12-22       Impact factor: 44.544

7.  Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes.

Authors:  Nicolas Goardon; Emmanouil Nikolousis; Alexander Sternberg; Wai-Kit Chu; Charles Craddock; Peter Richardson; Richard Benson; Mark Drayson; Graham Standen; Paresh Vyas; Sylvie Freeman
Journal:  Haematologica       Date:  2009-08       Impact factor: 9.941

8.  Acquired mutations in TET2 are common in myelodysplastic syndromes.

Authors:  Saskia M C Langemeijer; Roland P Kuiper; Marieke Berends; Ruth Knops; Mariam G Aslanyan; Marion Massop; Ellen Stevens-Linders; Patricia van Hoogen; Ad Geurts van Kessel; Reinier A P Raymakers; Eveline J Kamping; Gregor E Verhoef; Estelle Verburgh; Anne Hagemeijer; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

9.  Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

Authors:  Arjan A van de Loosdrecht; Canan Alhan; Marie Christine Béné; Matteo G Della Porta; Angelika M Dräger; Jean Feuillard; Patricia Font; Ulrich Germing; Detlef Haase; Christa H Homburg; Robin Ireland; Joop H Jansen; Wolfgang Kern; Luca Malcovati; Jeroen G Te Marvelde; Ghulam J Mufti; Kiyoyuki Ogata; Alberto Orfao; Gert J Ossenkoppele; Anna Porwit; Frank W Preijers; Stephen J Richards; Gerrit Jan Schuurhuis; Dolores Subirá; Peter Valent; Vincent H J van der Velden; Paresh Vyas; August H Westra; Theo M de Witte; Denise A Wells; Michael R Loken; Theresia M Westers
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

10.  Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.

Authors:  Kiyoyuki Ogata; Matteo G Della Porta; Luca Malcovati; Cristina Picone; Norio Yokose; Akira Matsuda; Taishi Yamashita; Hideto Tamura; Junichi Tsukada; Kazuo Dan
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941
View more
  3 in total

1.  Metal-Containing Polystyrene Beads as Standards for Mass Cytometry.

Authors:  Ahmed I Abdelrahman; Olga Ornatsky; Dmitry Bandura; Vladimir Baranov; Robert Kinach; Sheng Dai; Stuart C Thickett; Scott Tanner; Mitchell A Winnik
Journal:  J Anal At Spectrom       Date:  2010       Impact factor: 4.023

2.  Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS.

Authors:  Ganesan Keerthivasan; Yang Mei; Baobing Zhao; Ling Zhang; Chad E Harris; Juehua Gao; Ashley A Basiorka; Matthew J Schipma; James McElherne; Jing Yang; Amit K Verma; Andrea Pellagatti; Jacqueline Boultwood; Alan F List; David A Williams; Peng Ji
Journal:  Blood       Date:  2014-06-02       Impact factor: 22.113

3.  A pilot study on the usefulness of peripheral blood flow cytometry for the diagnosis of lower risk myelodysplastic syndromes: the "MDS thermometer".

Authors:  Ana Aires; Maria Dos Anjos Teixeira; Catarina Lau; Cláudia Moreira; Ana Spínola; Alexandra Mota; Inês Freitas; Jorge Coutinho; Margarida Lima
Journal:  BMC Hematol       Date:  2018-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.